Zelnorm (also Zelmac) is the brand name for the pharmaceutical product Tegaserod, marketed by Novartis as a remedy for irritable bowel syndrome (IBS) and constipation. Zelnorm was introduced to the U.S. market in 2002, subsequent to Food and Drug Administration (FDA) approval.
In 2007, the FDA asked Novartis to take Zelnorm off the market, based on an analysis of data by the agency. After receiving reports that Zelnorm might be tied to increased risk of stroke or heart attack, the FDA reviewed data from more than 18,000 patients. The study showed that the incidences of cardiovascular problems of people who took Zelnorm was more than 10 times the rate of those who took a placebo.
If you or someone you love has suffered injury after being prescribed Zelnorm, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.
Defective Drugs & Medical Devices Topics
Four Things to Know About Traffic Stops
You’re driving down the road; you glance down at the speedometer and see that you’re driv…Read More 11 Dec 2018, Tuesday
Small Claims Court: An Overview
Let’s say that you have a dispute with your landlord. You were asked to pay a security depo…Read More 10 Dec 2018, Monday
Divorce and Taxes
If you are facing a divorce, you know that there are plenty of difficult, even painful questi…Read More 07 Dec 2018, Friday